查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948963

哺乳动物群落拾取器市场：依群落类型、最终用户、应用、产品类型和技术划分，全球预测，2026-2032年

Mammalian Colony Picker Market by Colony Type, End User, Application, Product Type, Technology - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年哺乳动物群落拾取器市场价值为 1.2285 亿美元，预计到 2026 年将成长至 1.4072 亿美元，年复合成长率为 10.41%，到 2032 年将达到 2.458 亿美元。

主要市场统计数据
基准年 2025 1.2285亿美元
预计年份：2026年 1.4072亿美元
预测年份：2032年 2.458亿美元
复合年增长率 (%) 10.41%

本文简要概述了哺乳动物群体拾取技术，探讨了实验室整合的注意事项，并分析了其对研究操作和采购的战略意义。

本执行摘要重点分析哺乳动物群体拣选技术、其在实验室工作流程中的运作作用，以及其对依赖高效动物群体管理的机构的战略意义。旨在为高阶主管提供一份简明扼要、基于实证的概述，介绍近期趋势、应用驱动因素以及影响采购和实施决策的实际考虑。

机器人技术、成像技术和软体整合技术的快速发展如何重塑菌落挑选器的功能以及对大规模实验室工作流程的期望

由于自动化、成像和软体整合技术的快速发展，哺乳动物菌落分离技术正经历着变革性的转变。机器人技术和基于成像的分选技术的最新创新，使这项技术超越了简单的拾取和放置操作，发展成为能够原位识别表型和基因型标记的系统，从而在减少人为干预的情况下，实现更具选择性和可重复性的菌落分离。

2025年美国关税调整对实验室设备筹资策略、供应链韧性和供应商选择的影响

2025年生效的关税给采购某些用于资本密集型实验室设备和菌落挑选系统的进口零件带来了困难。这些关税迫使采购团队重新评估供应商选择、整体拥有成本，以及部署完全整合的海外系统和在国内采购模组化零件之间的平衡。

深入了解影响采购和研发优先事项的群体类型、最终用户需求、应用、产品类型和底层技术。

细分市场分析揭示了不同生物模型类型、最终用户、应用领域、产品类型和平台技术之间存在的显着需求模式，这些模式正在影响采购重点和产品蓝图。按动物群落类型划分，由于可用的遗传模型种类繁多，小鼠相容系统仍然是许多研究项目的主要操作重点；大鼠特异性平台在转化生理学和行为学研究中越来越受欢迎；而专门的仓鼠工作流程则继续在病毒学和代谢研究等专业领域得到应用。

关键区域的采用模式和服务生态系统会影响采购选择、采用速度和客户维繫策略。

区域趋势将影响部署时间表、服务模式和伙伴关係策略，进而打入市场策略和客户的部署计画产生实质影响。美洲地区学术机构、生物技术中心和受託研究机构（CRO）高度集中，因此自动化、高效能係统得到了广泛应用，并辅以强大的售后服务生态系统，从而支援快速部署和检验。

供应商之间的竞争源自于模组化架构、软体赋能服务、细分市场专业知识和整合检验支援。

主要企业的洞察凸显了领先供应商如何透过技术、服务和伙伴关係关係实现差异化，从而抓住策略机会。市场领导正投资于模组化架构，使客户能够从手动或半自动化工作流程扩展到完全整合的自动化平台，从而保护现有基本客群的价值并降低初始采用门槛。这些公司优先考虑互通性，提供 API 和资料汇出功能，以促进与实验室资讯管理系统和分析平台的整合。

为检查室管理人员提供切实可行的策略建议，以最大限度地提高投资回报率、降低营运风险并加速菌落挑选系统的可扩展实施。

产业领导者应采取多管齐下的策略来管理采购和营运风险，同时充分利用技术转型。首先，应优先考虑平台的可扩展性，选择支援模组化升级和软体整合的系统，以便随着工作流程的演变和新分析功能的出现调整投资。这可以降低系统过时的风险，并逐步提高实验室的处理能力和数据品质。

我们采用稳健的混合方法研究途径，结合一手访谈、技术审核、文献综述和营运案例研究，以检验我们关于技术和实施方面的发现。

本调查方法结合了定性访谈、供应商产品审核、技术文献综合分析以及与营运案例研究的检验，旨在从实证观点分析技术采纳及其对营运的影响。关键资讯包括与实验室主任、采购经理、自动化工程师和验证专家进行结构化访谈，以了解不同终端使用者环境下的决策驱动因素、挑战和服务期望。

整合技术整合、供应链弹性以及以细分市场主导的优先事项，以指导实验室自动化采购和营运执行。

总之，哺乳动物菌落挑选技术正处于一个转折点，成像、机器人和软体方面的进步正在融合，实现更具选择性、可重复性和可扩展性的工作流程。这些进步直接解决了现代实验室面临的操作挑战：高通量、严格的可追溯性以及因人工操作而导致的变异性降低。那些能够使其产品蓝图与互通性、强大的服务模式和检验支援一致的供应商，将更有能力满足受监管和高通量环境下最终用户的需求。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依群落类型分類的哺乳动物群落采摘市场

  • 仓鼠
  • 老鼠
  • 鼠

9. 哺乳动物群落拾取器市场（依最终用户划分）

  • 学术机构
    • 私人研究机构
    • 公立大学
  • 生技公司
  • CRO
  • 製药公司
    • 学名药生产商
    • 大型製药企业
    • 中型製药公司

第十章 依应用分類的哺乳动物群落拾取器市场

  • 癌症研究
  • 药物发现
    • 遗传模型
    • 高效能筛检
  • 基因研究
  • 干细胞研究
  • 毒理学研究

第十一章 哺乳类动物群落拾取器市场（依产品类型划分）

  • 自动化系统
  • 高效能係统
  • 手动系统
  • 软体解决方案

12. 哺乳动物群落拾取器市场（依技术划分）

  • 混合方法
  • 成像基地
  • 机器人
  • 限软体

第十三章 各地区哺乳动物群落采摘市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 哺乳动物群落采摘者市场（按群体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国哺乳动物群落采摘者市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国哺乳动物殖民地采摘市场

第十七章 中国的哺乳动物群落拾荒者市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ALS Automated Lab Solutions GmbH
  • Analytik Jena GmbH
  • Automata Technologies Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioRobotics Inc.
  • Cellink AB
  • COPAN Diagnostics, Inc.
  • Cytena GmbH（Bico集团旗下公司）
  • Danaher Corporation
  • Hamilton Company
  • Hudson Robotics, Inc.
  • Lab Services BV
  • Molecular Devices, LLC
  • Porvair PLC（Kbiosystems Ltd.）
  • Sartorius AG
  • SciRobotics Ltd.
  • Shimadzu Corporation
  • Singer Instruments Company Ltd.
  • Tecan Group Ltd.
Product Code: MRR-4F7A6D4FB90F

The Mammalian Colony Picker Market was valued at USD 122.85 million in 2025 and is projected to grow to USD 140.72 million in 2026, with a CAGR of 10.41%, reaching USD 245.80 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 122.85 million
Estimated Year [2026] USD 140.72 million
Forecast Year [2032] USD 245.80 million
CAGR (%) 10.41%

A concise orientation to mammalian colony picker technologies, laboratory integration considerations, and strategic implications for research operations and procurement

This executive summary introduces a focused analysis of mammalian colony picker technologies, their operational role within laboratory workflows, and the strategic implications for organizations relying on efficient animal colony management. The intent is to provide senior leaders with a concise, evidence-based orientation to recent technology developments, adoption drivers, and the practical considerations that shape procurement and deployment decisions.

The document synthesizes cross-functional perspectives from laboratory operations, animal welfare compliance, automation engineering, and R&D project planning to highlight where colony picking solutions deliver value, reduce manual bottlenecks, and enhance reproducibility. It situates these tools within contemporary laboratory demands, including higher throughput requirements, reproducibility pressures, and growing expectations for data traceability and integration with digital laboratory ecosystems.

Readers will find a structured narrative that connects technology attributes to user needs, surfaces regulatory and operational headwinds, and identifies strategic levers that organizations can use to align technology selection with research objectives. The summary sets the stage for deeper sections that analyze shifts in the competitive landscape, tariff-driven cost changes in the United States in 2025, segmentation-based insights, regional dynamics, and practical recommendations for industry leaders seeking to operationalize automation in animal colony management.

How rapid advances in robotics, imaging, and software integration are reshaping colony picker capabilities and laboratory workflow expectations at scale

The landscape for mammalian colony pickers is undergoing transformative shifts driven by rapid advances in automation, imaging, and software integration. Recent innovations in robotics and imaging-based selection have moved the technology beyond simple pick-and-place operations toward systems that can discern phenotypic and genotypic markers in situ, enabling more selective and reproducible colony isolation with lower human intervention.

Concurrently, hybrid solutions that combine robotic platforms with advanced imaging and software-only layers are redefining workflow architectures. These combinations allow laboratories to retrofit existing manual systems with intelligent overlays, decreasing capital intensity while accelerating adoption among institutions with constrained budgets. High-throughput systems are increasingly designed to integrate seamlessly with laboratory information management systems and electronic lab notebooks, enhancing traceability, auditability, and downstream analytics.

Operational priorities have also shifted: animal welfare regulations and institutional ethical standards are elevating the demand for systems that reduce handling stress and procedural variability. As a result, suppliers are emphasizing ergonomics, containment, and non-invasive imaging modalities. The convergence of automation and regulatory emphasis is creating a new category of differentiated offerings that compete on data quality, ease of validation, and the capacity to support complex experimental designs.

Finally, user expectations are evolving. End users expect turnkey solutions supported by robust training, remote diagnostics, and service models that minimize downtime. This evolution favors vendors that pair hardware excellence with scalable software and service ecosystems, creating an environment where platform extensibility and service responsiveness are as important as raw technical capability.

Impacts of 2025 United States tariff adjustments on procurement strategies, supply chain resilience, and vendor selection for laboratory equipment

The imposition of tariffs in the United States in 2025 introduced material procurement frictions for capital-intensive laboratory equipment and certain imported components used in colony picker systems. These tariff measures have compelled procurement teams to reassess vendor selection, total cost of ownership, and the balance between acquiring fully integrated overseas systems versus sourcing modular components domestically.

In response, laboratories have adopted several operational strategies. Some institutions have deferred non-essential upgrades and focused investments on software and retrofitting options that extend the life and functionality of existing platforms. Others have pivoted to suppliers with stronger local manufacturing footprints or diversified their vendor mix to include regional assemblers that can mitigate import cost exposure. For organizations with critical throughput needs, contractual renegotiations and longer-term service agreements have been used to lock in supply and spread cost risk over multiple fiscal periods.

Supply chain resilience has become a priority, with procurement leaders emphasizing dual sourcing for key components, increased inventory for long-lead items, and closer collaboration with vendors on lead-time visibility. At the same time, demand-side adjustments have included prioritizing systems that deliver rapid ROI through labor savings, improved reproducibility, and simplified validation, which can justify higher upfront costs incurred due to tariff impacts.

The tariff environment has also accelerated conversations about domestic manufacturing and localization strategies among vendors. Suppliers that can demonstrate production agility, modular architectures that allow for regional component substitution, and transparent cost structures are more competitive in this environment, as buyers increasingly value predictability and contractual clarity over marginal cost savings on individual purchases.

Segmentation-driven insight into colony type, end-user needs, applications, product types, and enabling technologies shaping procurement and R&D priorities

Segment analysis reveals nuanced demand patterns across biological model types, end users, applications, product types, and enabling technologies that shape procurement priorities and product roadmaps. In terms of colony type, systems that support mice remain the dominant operational focus for many research programs due to the breadth of genetic models available, while rat-focused platforms are gaining traction in translational physiology and behavioral studies, and hamster-specific workflows persist in specialized virology and metabolic research domains.

End-user segmentation clarifies distinct purchase drivers: academic institutes, which include both private research institutes and public universities, prioritize adaptability, cost-effectiveness, and training support to serve diverse experimental needs; biotech companies value throughput, integration with drug discovery pipelines, and vendor partnership models that support rapid iteration; contract research organizations seek scalable, validated systems that can be standardized across multiple client projects; and pharmaceutical companies, encompassing generic manufacturers, large pharma, and mid-sized pharma, look for compliance-ready platforms with strong documentation, qualification packages, and the ability to integrate with regulated data systems.

Application-based segmentation further differentiates demand. Cancer research workflows emphasize high-fidelity isolation of clonal populations and downstream phenotypic assays, while drug discovery programs-whether they focus on genetic models or high-throughput screening-demand systems that combine speed with traceable selection criteria. Genetic research and stem cell projects put a premium on gentle handling, sterility, and imaging precision, whereas toxicology studies prioritize throughput and standardized processing across large sample sets.

Product-type distinctions are equally consequential. Automated and high-throughput systems compete on speed and standardization, manual systems remain relevant where flexibility and low capital outlay are paramount, and software solutions are emerging as key enablers that deliver analytics, image recognition, and workflow orchestration. Finally, technology segmentation shows divergent adoption patterns: hybrid systems marry robotics with advanced imaging to balance capability and cost; imaging-based platforms excel where phenotypic selection is critical; robotic approaches drive repeatability in high-volume contexts; and software-only options enable retrofits and analytics-driven productivity gains. Collectively, these segmentation layers inform procurement decisions, vendor positioning, and roadmap investments by highlighting where capability trade-offs align with specific research and operational priorities.

How regional adoption patterns and service ecosystems across major geographies influence procurement choices, deployment speed, and retention strategies

Regional dynamics shape adoption timelines, service models, and partnership strategies in ways that materially affect vendor go-to-market and customer implementation planning. In the Americas, strong concentrations of academic centers, biotech hubs, and contract research organizations create pockets of high adoption for automated and high-throughput systems, complemented by a robust service and aftermarket ecosystem that supports rapid deployment and validation.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory frameworks, funding cycles, and institutional procurement practices vary substantially between markets. This region favors vendors that can offer local service capabilities, customizable validation packages, and models that address public procurement constraints, particularly among public universities and national research institutes.

Asia-Pacific exhibits a mix of fast-growing demand in translational biotech clusters and large-scale public research investments, driving interest in modular, cost-effective solutions that can be rapidly scaled. The region also demonstrates strong interest in hybrid and imaging-based approaches that support genetic research and high-throughput screening initiatives, with local manufacturers increasingly contributing to the supply base.

Across all regions, the ability to provide training, remote diagnostics, and flexible financing or leasing options is a differentiator. Vendors that tailor their commercial and service models to regional procurement realities and that invest in local partnerships tend to shorten sales cycles and improve long-term retention.

Competitive differentiation among suppliers driven by modular architectures, software-enabled services, niche specializations, and integrated validation support

Key company insights focus on how leading suppliers differentiate along technology, service, and partnership dimensions to capture strategic opportunities. Market leaders invest in modular architectures that permit customers to scale from manual or semi-automated workflows to fully integrated automated platforms, thereby protecting installed-base value and lowering barriers to initial adoption. These firms prioritize interoperability, offering APIs and data-export capabilities that facilitate integration with laboratory information management systems and analytics platforms.

Another noteworthy trend among competitive vendors is the bundling of hardware with software subscription models that include image-analysis algorithms, predictive maintenance, and remote support. This shift toward bundled offerings supports recurring revenue streams and aligns vendor incentives with customer uptime and performance. Companies that support strong validation documentation, on-site qualification services, and regulatory support for clinical and preclinical environments gain preference among regulated end users such as pharmaceutical developers.

Smaller, specialized firms are pursuing differentiation through niche capabilities-such as advanced imaging modalities, gentle handling for sensitive cell types, or optimized workflows for specific applications like stem cell clonal isolation. These players often partner with larger integrators or enter into co-development agreements with research institutions to validate and commercialize targeted solutions. Strategic M&A and partnership activity is likely to continue as larger players seek to fill capability gaps and smaller innovators look to scale distribution and service reach.

Finally, service quality, global support footprint, and the availability of localized training resources are recurring selection criteria cited by end users. Vendors that combine technical excellence with a strong service ethos tend to obtain higher customer satisfaction and increased opportunity for cross-selling additional modules and software services.

Actionable strategic recommendations for laboratory leaders to maximize ROI, reduce operational risk, and accelerate scalable adoption of colony picker systems

Industry leaders should adopt a multi-pronged strategy to capitalize on technology shifts while managing procurement and operational risks. First, prioritize platform extensibility by selecting systems that support modular upgrades and software integrations so that investments can be adapted as workflows evolve and new analytical capabilities emerge. This reduces obsolescence risk and enables incremental enhancement of laboratory throughput and data quality.

Second, strengthen supplier relationships by negotiating service-level agreements that include predictive maintenance, remote diagnostics, and flexible training packages. Such agreements reduce downtime and build operational resilience, which is especially important when component lead times are uncertain. Third, evaluate hybrid acquisition models-combining capital purchases for core capabilities with software subscriptions or leasing for scaling-allowing organizations to balance budgetary constraints with the need for rapid capability expansion.

Fourth, invest in internal capability building by creating cross-functional teams that include lab scientists, IT, procurement, and validation specialists to oversee implementation and continuous improvement. These teams accelerate adoption, ensure compliance with welfare and regulatory standards, and translate vendor roadmaps into actionable lab-level milestones. Fifth, prioritize interoperability and data governance policies that enable integration of colony picker outputs into broader laboratory information systems to maximize traceability and analytical value.

Finally, adopt a phased rollout approach for new systems, beginning with pilot projects that validate operational benefits and integration pathways. Use pilot outcomes to refine standard operating procedures, training curricula, and qualification documentation before wider deployment. This pragmatic approach reduces implementation risk and accelerates realization of productivity gains.

A robust mixed-methods research approach combining primary interviews, technical audits, literature synthesis, and operational case studies to validate technology and deployment insights

The research methodology combines primary qualitative interviews, vendor product audits, technical literature synthesis, and triangulation with operational case studies to construct an evidence-based perspective on technology adoption and operational impact. Primary inputs included structured interviews with laboratory directors, procurement leads, automation engineers, and validation specialists to capture decision drivers, pain points, and service expectations across diverse end-user contexts.

Supplementing primary research, a technical audit of supplier offerings was performed to map feature sets, integration capabilities, and service models. This audit involved hands-on demonstrations, specification reviews, and analysis of software interoperability. Peer-reviewed literature and white papers were analyzed to ground claims about imaging, robotics, and colony handling efficacy, with emphasis on reproducibility, cell viability, and handling stress metrics where available.

Operational case studies were incorporated to illustrate real-world deployments, pilot outcomes, and validation processes. These case studies provided insight into implementation timelines, training requirements, and typical operational adjustments needed to integrate automation into existing workflows. Finally, findings were validated through follow-up interviews and cross-referenced against publicly available regulatory guidance to ensure that recommendations and observations are consistent with best practices in animal welfare and laboratory quality management.

Synthesis of technological convergence, supply resilience, and segmentation-driven priorities to guide procurement and operational execution for laboratory automation

In conclusion, mammalian colony picker technologies are at an inflection point where improvements in imaging, robotics, and software are converging to deliver more selective, reproducible, and scalable workflows. These advances respond directly to the operational imperatives of modern laboratories: higher throughput, tighter traceability, and reduced manual variability. Vendors that align product roadmaps with interoperability, strong service models, and validation support will be best positioned to meet the needs of regulated and high-throughput end users.

Geopolitical and policy-driven forces, exemplified by tariff changes, have prompted laboratories and vendors to reconsider sourcing, inventory strategies, and service agreements, elevating supply chain resilience as a competitive dimension. Segmentation analysis underscores that diverse user needs-from academic flexibility to pharmaceutical compliance-require differentiated commercial and technical approaches. Furthermore, regional dynamics demonstrate that localization of service, training, and financing can materially accelerate adoption.

For decision-makers, the practical path forward involves prioritizing extensible platforms, formalizing supplier partnerships with robust service commitments, and executing phased implementations that translate pilot success into sustained operational improvements. When combined with rigorous data governance and integration strategies, these steps enable laboratories to harness automation not only for productivity gains but also for higher data fidelity and reproducibility across experimental programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Mammalian Colony Picker Market, by Colony Type

  • 8.1. Hamster
  • 8.2. Mouse
  • 8.3. Rat

9. Mammalian Colony Picker Market, by End User

  • 9.1. Academic Institutes
    • 9.1.1. Private Research Institutes
    • 9.1.2. Public Universities
  • 9.2. Biotech Companies
  • 9.3. CROs
  • 9.4. Pharmaceutical Companies
    • 9.4.1. Generic Manufacturers
    • 9.4.2. Large Pharma
    • 9.4.3. Mid-Sized Pharma

10. Mammalian Colony Picker Market, by Application

  • 10.1. Cancer Research
  • 10.2. Drug Discovery
    • 10.2.1. Genetic Models
    • 10.2.2. High-Throughput Screening
  • 10.3. Genetic Research
  • 10.4. Stem Cell Research
  • 10.5. Toxicology Studies

11. Mammalian Colony Picker Market, by Product Type

  • 11.1. Automated Systems
  • 11.2. High-Throughput Systems
  • 11.3. Manual Systems
  • 11.4. Software Solutions

12. Mammalian Colony Picker Market, by Technology

  • 12.1. Hybrid
  • 12.2. Imaging-Based
  • 12.3. Robotic
  • 12.4. Software-Only

13. Mammalian Colony Picker Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Mammalian Colony Picker Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Mammalian Colony Picker Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Mammalian Colony Picker Market

17. China Mammalian Colony Picker Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ALS Automated Lab Solutions GmbH
  • 18.6. Analytik Jena GmbH
  • 18.7. Automata Technologies Ltd.
  • 18.8. Becton, Dickinson and Company
  • 18.9. Bio-Rad Laboratories, Inc.
  • 18.10. BioRobotics Inc.
  • 18.11. Cellink AB
  • 18.12. COPAN Diagnostics, Inc.
  • 18.13. Cytena GmbH (part of Bico Group)
  • 18.14. Danaher Corporation
  • 18.15. Hamilton Company
  • 18.16. Hudson Robotics, Inc.
  • 18.17. Lab Services B.V.
  • 18.18. Molecular Devices, LLC
  • 18.19. Porvair PLC (Kbiosystems Ltd.)
  • 18.20. Sartorius AG
  • 18.21. SciRobotics Ltd.
  • 18.22. Shimadzu Corporation
  • 18.23. Singer Instruments Company Ltd.
  • 18.24. Tecan Group Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAMMALIAN COLONY PICKER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAMMALIAN COLONY PICKER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HAMSTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HAMSTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HAMSTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY MOUSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY MOUSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY MOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY RAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY RAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY RAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PUBLIC UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PUBLIC UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PUBLIC UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY CROS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY CROS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY CROS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GENERIC MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GENERIC MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY LARGE PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY LARGE PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY MID-SIZED PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY MID-SIZED PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY MID-SIZED PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY CANCER RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY CANCER RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GENETIC MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GENETIC MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GENETIC MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GENETIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GENETIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GENETIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY TOXICOLOGY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY TOXICOLOGY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HIGH-THROUGHPUT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HIGH-THROUGHPUT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HIGH-THROUGHPUT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY SOFTWARE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY SOFTWARE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY IMAGING-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY IMAGING-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY IMAGING-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY SOFTWARE-ONLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY SOFTWARE-ONLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY SOFTWARE-ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS MAMMALIAN COLONY PICKER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. GCC MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 178. GCC MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 179. GCC MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. GCC MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. G7 MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 205. G7 MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 206. G7 MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. NATO MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. NATO MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 214. NATO MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 215. NATO MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. NATO MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 217. NATO MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL MAMMALIAN COLONY PICKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, BY COLONY TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA MAMMALIAN COLONY PICKER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)